Xiang L - Search Results

1

Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer.

Wang J, Zhang Y, Zhang G, Xiang L, Pang H, Xiong K, Lu Y, Li J, Dai J, Lin S, Fu S. Wang J, et al. Among authors: xiang l. Drug Deliv. 2022 Dec;29(1):588-599. doi: 10.1080/10717544.2022.2036871. Drug Deliv. 2022. PMID: 35156493 Free PMC article.

2

Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.

Xiang L, Zhang JW, Lin S, Luo HQ, Wen QL, He LJ, Shang CL, Ren PR, Yang HR, Pang HW, Yang B, He HL, Chen Y, Wu JB. Xiang L, et al. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1027-1034. doi: 10.1016/j.ijrobp.2015.04.019. Epub 2015 Apr 17. Int J Radiat Oncol Biol Phys. 2015. PMID: 26194678 Clinical Trial.

3

Oncogenic role of the TP53-induced glycolysis and apoptosis regulator in nasopharyngeal carcinoma through NF-κB pathway modulation.

Zhao M, Fan J, Liu Y, Yu Y, Xu J, Wen Q, Zhang J, Fu S, Wang B, Xiang L, Feng J, Wu J, Yang L. Zhao M, et al. Among authors: xiang l. Int J Oncol. 2016 Feb;48(2):756-64. doi: 10.3892/ijo.2015.3297. Epub 2015 Dec 17. Int J Oncol. 2016. PMID: 26691054

4

JNK pathway inhibition enhances chemotherapeutic sensitivity to Adriamycin in nasopharyngeal carcinoma cells.

Liu Y, Feng J, Zhao M, Wu J, Fan J, Wen Q, Xu J, Zhang J, Fu S, Wang B, Lu Y, Xiong K, Xiang L, Zhang Y, Yang L. Liu Y, et al. Among authors: xiang l. Oncol Lett. 2017 Aug;14(2):1790-1794. doi: 10.3892/ol.2017.6349. Epub 2017 Jun 8. Oncol Lett. 2017. PMID: 28789411 Free PMC article.

5

TP53-induced glycolysis and apoptosis regulator is indispensable for mitochondria quality control and degradation following damage.

Feng J, Luo L, Liu Y, Fu S, Chen J, Duan X, Xiang L, Zhang Y, Wu J, Fan J, Wen Q, Zhang Y, Yang J, Peng J, Zhao M, Yang L. Feng J, et al. Among authors: xiang l. Oncol Lett. 2018 Jan;15(1):155-160. doi: 10.3892/ol.2017.7303. Epub 2017 Oct 31. Oncol Lett. 2018. PMID: 29375708 Free PMC article.

6

Preliminary report of a single-channel applicator in high dose rate afterloading brachytherapy for cervical cancer.

Li D, Wen E, Zhang Y, Wu Z, Pang H, Ren P, Shang C, He L, Zhang J, Xiang L, Yang H, Liu Q, Wen Q, Fan J, Lin S, Wu J. Li D, et al. Among authors: xiang l. Cancer Sci. 2018 Dec;109(12):3953-3961. doi: 10.1111/cas.13845. Epub 2018 Nov 28. Cancer Sci. 2018. PMID: 30353607 Free PMC article. Clinical Trial.

7

Nutritional outcomes after radiotherapy target volume reduction for nasopharyngeal cancer: a Phase III trial.

Xiang L, Rong JF, Pang HW, He HL, Chen Y, Wu JB, Wang YS. Xiang L, et al. Future Oncol. 2020 Mar;16(9):427-437. doi: 10.2217/fon-2019-0785. Epub 2020 Feb 27. Future Oncol. 2020. PMID: 32102557 Clinical Trial.

8

Development of a Radiotherapy Localisation Computed Tomography-Based Radiomic Model for Predicting Survival in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy Following Induction Chemotherapy.

Li X, Chen H, Zhao F, Zheng Y, Pang H, Xiang L. Li X, et al. Among authors: xiang l. Cancer Control. 2022 Jan-Dec;29:10732748221076820. doi: 10.1177/10732748221076820. Cancer Control. 2022. PMID: 35271403 Free PMC article.

9

Bacteria-driven hypoxia targeting delivery of chemotherapeutic drug proving outcome of breast cancer.

Xiao S, Shi H, Zhang Y, Fan Y, Wang L, Xiang L, Liu Y, Zhao L, Fu S. Xiao S, et al. Among authors: xiang l. J Nanobiotechnology. 2022 Apr 2;20(1):178. doi: 10.1186/s12951-022-01373-1. J Nanobiotechnology. 2022. PMID: 35366890 Free PMC article.

10

Effect of 3-Dimensional Interstitial High-Dose-Rate Brachytherapy With Regional Metastatic Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: 5-Year Follow-up of a Phase 2 Clinical Trial.

Xiang L, Ren PR, Li HX, Ye H, Pang HW, Wen QL, Zhang JW, He LH, Shang CL, Yang BY, Lin SL, Wu JW. Xiang L, et al. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):347-355. doi: 10.1016/j.ijrobp.2022.07.028. Epub 2022 Jul 25. Int J Radiat Oncol Biol Phys. 2023. PMID: 35901979 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,432 results

Search Page

Filters